The Optoelectronic Medical Beauty Equipment ecosystem spans upstream component suppliers, midstream system manufacturers and integrators, and downstream distribution and clinical adoption. Raw‑material and semiconductor providers deliver lasers, LEDs, and sensor chips to OEMs that assemble treatment platforms. System integrators combine optical modules with software, safety controls, and ergonomic housings, creating market‑ready devices. Distributors and specialized channel partners convey finished units to dermatology clinics, aesthetic centers, and hospital outpatient departments. Value is generated through technology licensing, device sales, and recurring service contracts, while revenue capture is distributed across component margins, equipment pricing, and post‑sale service fees. Financing and leasing partners enable clinics to acquire capital‑intensive units, spreading cost over treatment cycles and influencing purchase timing. This framework defines the boundaries for a value chain analysis of the sector.